Docosane
CAS No. 629-97-0
Docosane( —— )
Catalog No. M29407 CAS No. 629-97-0
Docosane is a natural product that can be used in the synthesis of structural composites with thermal energy storage or release capability.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameDocosane
-
NoteResearch use only, not for human use.
-
Brief DescriptionDocosane is a natural product that can be used in the synthesis of structural composites with thermal energy storage or release capability.
-
DescriptionDocosane is a natural product that can be used in the synthesis of structural composites with thermal energy storage or release capability.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number629-97-0
-
Formula Weight310.61
-
Molecular FormulaC22H46
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 16.67 mg/mL (53.67 mM)
-
SMILESCCCCCCCCCCCCCCCCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
LysoTracker Red
LysoTracker Red (LysoTracker Red DND-99) is a fluorescent probe compound for lysosomal capture, a transport substrate for P-glycoprotein, with a maximum excitation/emission wavelength of 577/590 nm.LysoTracker Red can be used for the long-term tracking of acidic vesicles.
-
SARS-CoV-2 Mpro-IN-9
SARS-CoV-2 Mpro-IN-9 (compound c7), a nonpeptidic, noncovalent inhibitor of SARS-CoV-2 main protease (Mpro), exhibits potent inhibitory action (IC50 = 0.085 μM) and improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties.
-
26Rfa, Hypothalamic ...
This human neuropeptide of the RFamide peptide family with orexigenic activity may be also involved in the control of feeding behavior. The 26RFa gene is exclusively expressed in the ventromedial hypothalamic nucleus and in the lateral hypothalamic area. The primary structures of human, rat, and frog 26RFa exhibit ≈80% identity. Other data suggest also the potential role of the 26RFa peptide in the control of the gonadotropic axis.
Cart
sales@molnova.com